BioSpace News Archive

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has entered into a securities purchase agreement with certain funds managed by Consonance Capital Management, a prominent healthcare-focused institutional investor. Stereotaxis is issuing approximately 3.66 million shares of registered common stock at a purchase price of $4.10 per share, for gross and net pr

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the 2020 Jefferies Virtual Healthcare Conference on June 2, 2020, at 1:30 p.m. ET. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A replay

Nordic Nanovector ASA announces its results for the first quarter 2020. A presentation by Nordic Nanovector’s senior management team will take place via a webcast at 08:30 am CET.

Hutchison China MediTech Limited and BeiGene, Ltd. announced that they have entered into a clinical collaboration agreement to evaluate the safety, tolerability and efficacy of combining two of Chi-Med’s drug candidates, surufatinib and fruquintinib, with BeiGene’s anti-PD-1 antibody tislelizumab, for the treatment of various solid tumor cancers, in the U.S., Europe, China and Australia.

Novasep announced the signature of an agreement for the development and manufacturing of LYS-GM101, an AAVrh10-based gene therapy drug candidate for the treatment of GM1 Gangliosidosis, a rare neuronopathic lysosomal storage disorder.

Top line results from the company’s pivotal phase 2 study HORIZON were presented and showed a 26% Overall Response Rate (ORR) of melflufen in triple-class refractory multiple myeloma patients

Sterility refers to the non-appearance of viable microorganisms. This testing confirms that products are free from any kind of viable microorganisms.

Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering.

Next Generation Sequencing is utilized to execute different applications, for instance, biomarker revelation, oncology thinks about, customized solution, rural and creature research, and others.

Metabolomics is the examination of small molecules, commonly known as metabolites.